Vitamin D₃supplementation and childhood diarrhea: a randomized controlled trial

Area of Science:

• Pediatrics
• Infectious Diseases
• Nutritional Science

Background:

• Diarrheal illnesses are a major cause of childhood morbidity and mortality globally.
• Vitamin D deficiency is prevalent in many populations, and vitamin D supplementation has been explored for various health benefits.
• The role of vitamin D in preventing infectious diseases, including diarrhea, requires further investigation in diverse settings.

Purpose of the Study:

• To evaluate the efficacy of vitamin D3 supplementation in preventing first and recurrent diarrheal episodes in high-risk infants.
• To assess the impact of vitamin D3 on the time to first diarrheal illness and the overall risk of diarrhea.

Main Methods:

• A double-blind, placebo-controlled trial involving 3046 infants aged 1-11 months in Kabul, Afghanistan.
• Participants received 6 quarterly doses of oral vitamin D3 (cholecalciferol 100,000 IU) or placebo.
• Diarrheal episodes were monitored over 18 months via active and passive surveillance; statistical analyses included Kaplan-Meier plots and Poisson regression models.

Main Results:

• No significant difference in time to first diarrheal illness between vitamin D3 and placebo groups (log rank P = .55).
• Incidence rates of diarrhea were similar in both groups (3.43 vs. 3.59 episodes per child-year).
• Vitamin D3 supplementation showed no effect on the risk of recurrent diarrheal disease in intention-to-treat or per-protocol analyses, regardless of age, nutritional status, or season.

Conclusions:

• Quarterly vitamin D3 supplementation did not reduce the incidence or risk of diarrheal disease in this study population.
• The findings suggest that similar supplementation strategies may not be beneficial for comparable populations.
• Further research in different settings is recommended to fully understand vitamin D3's role in diarrheal disease prevention.